These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 9076737)
1. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737 [TBL] [Abstract][Full Text] [Related]
2. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Li X; Lockatell CV; Johnson DE; Mobley HL Mol Microbiol; 2002 Aug; 45(3):865-74. PubMed ID: 12139630 [TBL] [Abstract][Full Text] [Related]
3. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Li X; Johnson DE; Mobley HL Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487 [TBL] [Abstract][Full Text] [Related]
4. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection. Zhao H; Li X; Johnson DE; Mobley HLT Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():185-195. PubMed ID: 10206698 [TBL] [Abstract][Full Text] [Related]
5. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection. Zhao H; Thompson RB; Lockatell V; Johnson DE; Mobley HL Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875 [TBL] [Abstract][Full Text] [Related]
6. Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. Lane MC; Li X; Pearson MM; Simms AN; Mobley HL J Bacteriol; 2009 Mar; 191(5):1382-92. PubMed ID: 19114498 [TBL] [Abstract][Full Text] [Related]
7. Phase Variation of the mrp Fimbrial Promoter. Pearson MM Methods Mol Biol; 2019; 2021():121-127. PubMed ID: 31309501 [TBL] [Abstract][Full Text] [Related]
8. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene. Bahrani FK; Mobley HL J Bacteriol; 1993 Jan; 175(2):457-64. PubMed ID: 8093447 [TBL] [Abstract][Full Text] [Related]
9. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Jansen AM; Lockatell V; Johnson DE; Mobley HL Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655 [TBL] [Abstract][Full Text] [Related]
11. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Bryan A; Roesch P; Davis L; Moritz R; Pellett S; Welch RA Infect Immun; 2006 Feb; 74(2):1072-83. PubMed ID: 16428754 [TBL] [Abstract][Full Text] [Related]
12. New aspects of RpoE in uropathogenic Proteus mirabilis. Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796 [TBL] [Abstract][Full Text] [Related]
13. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Gally DL; Leathart J; Blomfield IC Mol Microbiol; 1996 Aug; 21(4):725-38. PubMed ID: 8878036 [TBL] [Abstract][Full Text] [Related]
14. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418 [TBL] [Abstract][Full Text] [Related]
15. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373 [TBL] [Abstract][Full Text] [Related]
17. The Pai-associated leuX specific tRNA5(Leu) affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression. Ritter A; Gally DL; Olsen PB; Dobrindt U; Friedrich A; Klemm P; Hacker J Mol Microbiol; 1997 Sep; 25(5):871-82. PubMed ID: 9364913 [TBL] [Abstract][Full Text] [Related]
18. DNA sequence heterogeneity in Fim tyrosine-integrase recombinase-binding elements and functional motif asymmetries determine the directionality of the fim genetic switch in Escherichia coli K-12. McCusker MP; Turner EC; Dorman CJ Mol Microbiol; 2008 Jan; 67(1):171-87. PubMed ID: 18034794 [TBL] [Abstract][Full Text] [Related]
19. Differential temperature modulation by H-NS of the fimB and fimE recombinase genes which control the orientation of the type 1 fimbrial phase switch. Olsen PB; Schembri MA; Gally DL; Klemm P FEMS Microbiol Lett; 1998 May; 162(1):17-23. PubMed ID: 9595659 [TBL] [Abstract][Full Text] [Related]
20. Repression of bacterial motility by a novel fimbrial gene product. Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]